APA (7th ed.) Citation

Vernieri, C., Dieci, M., Caputo, R., Vigneri, P., Giuliano, M., Curigliano, G., . . . Ligorio, F. (2025). 498P Impact of estrogen receptor expression on real-world effectiveness of first-line ET+CDK4/6i in patients with HR+/HER2- advanced BC. Annals of Oncology, 36, S408. https://doi.org/10.1016/j.annonc.2025.08.921

Chicago Style (17th ed.) Citation

Vernieri, C., et al. "498P Impact of Estrogen Receptor Expression on Real-world Effectiveness of First-line ET+CDK4/6i in Patients with HR+/HER2- Advanced BC." Annals of Oncology 36 (2025): S408. https://doi.org/10.1016/j.annonc.2025.08.921.

MLA (9th ed.) Citation

Vernieri, C., et al. "498P Impact of Estrogen Receptor Expression on Real-world Effectiveness of First-line ET+CDK4/6i in Patients with HR+/HER2- Advanced BC." Annals of Oncology, vol. 36, 2025, p. S408, https://doi.org/10.1016/j.annonc.2025.08.921.